NRAS Mutations in Cutaneous T Cell Lymphoma (CTCL) Sensitize Tumors Towards Treatment With the Multikinase Inhibitor Sorafenib

Oncotarget - United States
doi 10.18632/oncotarget.17669
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Eritroderma Yang Disebabkan Cutaneous T-Cell Lymphoma (CTCL)

Media Dermato Venereologica Indonesiana
2019English

Ectopic Expression of Cancer Testis Antigens in Cutaneous T-Cell Lymphoma (CTCL) Patients

Journal of the American Academy of Dermatology
Dermatology
2015English

Cutaneous T Cell Lymphoma (CTCL) Superimposed on Disseminated Cutaneous Leishmaniasis (DCL) in an Immunocompromised Female From Yemen

International Journal of Clinical Dermatology & Research
2017English

165 Contribution of TOX1 and STAT3 Pathways to the Development of Cutaneous T-Cell Lymphoma (CTCL)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Treatment of Cutaneous T-Cell Lymphoma: An Update

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1993English

The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-Cell Lymphoma (CTCL)

Clinical Cancer Research
Cancer ResearchOncology
2015English

A Case of Cutaneous T-Cell Lymphoma (CTCL) Accompanied by Red Papules and Subcutaneous Nodules With Severe Itching

Skin Cancer
2003English

Cutaneous T-Cell Lymphoma With Nasal Necrosis

Archives of Plastic Surgery
Surgery
2015English

Orphan Designation: Mogamulizumab, Treatment of Cutaneous T-Cell Lymphoma

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy